I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles

被引：46

作者：

Anilkumar, Gopinadhan N. ^{[1
]}

Lesburg, Charles A. ^{[1
]}

Selyutin, Oleg ^{[1
]}

Rosenblum, Stuart B. ^{[1
]}

Zeng, Qingbei ^{[1
]}

Jiang, Yueheng ^{[1
]}

Chan, Tin-Yau ^{[1
]}

Pu, Haiyan ^{[1
]}

Vaccaro, Henry ^{[1
]}

Wang, Li ^{[1
]}

Bennett, Frank ^{[1
]}

Chen, Kevin X. ^{[1
]}

Duca, Jose ^{[1
]}

Gavalas, Stephen ^{[1
]}

Huang, Yuhua ^{[1
]}

Pinto, Patrick ^{[1
]}

Sannigrahi, Mousumi ^{[1
]}

Velazquez, Francisco ^{[1
]}

Venkatraman, Srikanth ^{[1
]}

Vibulbhan, Bancha ^{[1
]}

Agrawal, Sony ^{[1
]}

Butkiewicz, Nancy ^{[1
]}

Feld, Boris ^{[1
]}

Ferrari, Eric ^{[1
]}

He, Zhiqing ^{[1
]}

Jiang, Chuan-kui ^{[1
]}

Palermo, Robert E. ^{[1
]}

Mcmonagle, Patricia ^{[1
]}

Huang, H. -C. ^{[1
]}

Shih, Neng-Yang ^{[1
]}

Njoroge, George ^{[1
]}

Kozlowski, Joseph A. ^{[1
]}

机构：

[1] Merck Res Labs, Kenilworth, NJ 07033 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 18期

关键词：

HCV; NS5B polymerase; HEPATITIS-C VIRUS; DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; INFECTION;

D O I：

10.1016/j.bmcl.2011.07.021

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

SAR development of indole-based palm site inhibitors of HCV NS5B polymerase exemplified by initial indole lead 1 (NS5B IC(50) = 0.9 mu M, replicon EC(50) > 100 mu M) is described. Structure-based drug design led to the incorporation of novel heterocyclic moieties at the indole C3-position which formed a bidentate interaction with the protein backbone. SAR development resulted in leads 7q (NS5B IC(50) = 0.032 mu M, replicon EC(50) = 1.4 mu M) and 7r (NS5B IC(50) = 0.017 mu M, replicon EC(50) = 0.3 mu M) with improved enzyme and replicon activity. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：5336 / 5341

页数：6

共 50 条

[31] Novel indole derivatives as hepatitis C virus NS5B polymerase inhibitors: Pharmacophore modeling and 3D QSAR studies
Varun, G.
Lokesh, M.
Sandeep, M.
Shahbazi, Sajad
Reddy, G. Deepak
BANGLADESH JOURNAL OF PHARMACOLOGY, 2014, 9 (03) : 290 - 297
[32] 3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymerase
Hendricks, Robert T.
Spencer, Stacey R.
Blake, James F.
Fell, Jay B.
Fischer, John P.
Stengel, Peter J.
Leveque, Vincent J. P.
LePogam, Sophie
Rajyaguru, Sonal
Najera, Isabel
Josey, John A.
Swallow, Steven
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (02) : 410 - 414
[33] Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
Antonysamy, Stephen S.
Aubol, Brandon
Blaney, Jeff
Browner, Michelle F.
Giannetti, Anthony M.
Harris, Seth F.
Hebert, Normand
Hendle, Joerg
Hopkins, Stephanie
Jefferson, Elizabeth
Kissinger, Charles
Leveque, Vincent
Marciano, David
McGee, Ethel
Najera, Isabel
Nolan, Brian
Tomimoto, Masaki
Torres, Eduardo
Wright, Tobi
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2990 - 2995
[34] A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors
Chase, Robert
Skelton, Angela
Xia, Ellen
Curry, Stephanie
Liu, Shaotang
McMonagle, Patricia
Huang, H. -C.
Tong, Xiao
ANTIVIRAL RESEARCH, 2009, 84 (02) : 178 - 184
[35] Etodolac Thiosemicarbazides: A novel class of hepatitis C virus NS5B polymerase inhibitors
Cikla, Pelin
Arora, Payal
Basu, Amartya
Talele, Tanaji T.
Kaushik-Basu, Neerja
Kucukguzel, S. Guniz
MARMARA PHARMACEUTICAL JOURNAL, 2013, 17 (02) : 138 - 146
[36] Discovery of pentacyclic compounds as potent inhibitors of hepatitis C virus NS5B RNA polymerase
Habermann, Joerg
Capito, Elena
Ferreira, Maria del Rosario Rico
Koch, Uwe
Narjes, Frank
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 633 - 638
[37] The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase
Jackson, Randy W.
LaPorte, Matthew G.
Herbertz, Torsten
Draper, Tandy L.
Gaboury, Janet A.
Rippin, Susan R.
Patel, Ravi
Chunduru, Srinivas K.
Benetatos, Christopher A.
Young, Dorothy C.
Burns, Christopher J.
Condon, Stephen M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (11) : 3227 - 3231
[38] Finger-loop inhibitors of the HCV NS5b polymerase. Part 1: Discovery and optimization of novel 1,6-and 2,6-macrocyclic indole series
McGowan, David
Vendeville, Sandrine
Lin, Tse-I
Tahri, Abdellah
Hu, Lili
Cummings, Maxwell D.
Amssoms, Katie
Berke, Jan Martin
Canard, Maxime
Cleiren, Erna
Dehertogh, Pascale
Last, Stefaan
Fransen, Els
Van der Helm, Elisabeth
Van den Steen, Iris
Vijgen, Leen
Rouan, Marie-Claude
Fanning, Gregory
Nyanguile, Origene
Van Emelen, Kristof
Simmen, Kenneth
Raboisson, Pierre
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (13) : 4431 - 4436
[39] QSAR and Molecular Modeling Studies on a Series of Indole-based Pyridone Analogues as HCV NS5B Polymerase Inhibitors
Singh, Neelu
Shaik, Basheerulla
Agrawal, Neeraj
Anita, K.
Agrawal, Vijay K.
Gupta, Satya P.
LETTERS IN DRUG DESIGN & DISCOVERY, 2016, 13 (08) : 757 - 770
[40] Design and evaluation of novel tetracyclic benzofurans as palm site allosteric inhibitors of HCV NS5B polymerase
Liu, Hong
Dai, Xing
He, Shuwen
Brockunier, Linda
Marcantonio, Karen
Ludmerer, Steven W.
Li, Fangbiao
Feng, Kung-, I
Nargund, Ravi P.
Palani, Anandan
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (24)

← 1 2 3 4 5 →